ALFA Finder| Metric | H1 FY27 | H2 FY26 | H1 FY26 |
|---|---|---|---|
| Revenue from operations | 193.5 | 231.6 | 143.9 |
| Other income | 0.3 | -0.0 | 0.3 |
| Total income | 193.8 | 231.6 | 144.2 |
| Profit before exceptional items & tax | 14.6 | 14.6 | 8.8 |
| Profit before tax | 14.6 | 14.6 | 8.8 |
| Net profit | 10.7 | 10.6 | 5.5 |
| Operating margin | 7.5% | 6.3% | 6.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +94.50% |
|---|---|
| Net profit, quarter on quarter | +0.90% |
| Revenue, year on year | +34.50% |
| Operating profit, year on year | +68.20% |
| Operating profit, quarter on quarter | -2.10% |
BSE results filing, BSE: 544930. Figures extracted from the filing.
Injecto Polymers Ltd: key numbers
- Share price
- ₹95.12
- Market cap
- ₹197.8 Cr
- Revenue (annual)
- ₹375.5 Cr
- Net profit (annual)
- ₹16.01 Cr
- P/E (TTM)
- 12.3×Sector 46.8×
- Promoter holding
- 64.35%
- FII holding
- 8.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Injecto Polymers Ltd
All →Injecto Polymers Other Announcement
Injecto Polymers filed the first monitoring agency report on its IPO proceeds for the quarter ended 30 September 2026. The report states no deviation from the stated objects.
Injecto Polymers Board Meeting Date
Injecto Polymers Ltd has scheduled a board meeting for November 11, 2026. The board will consider half-yearly unaudited financial results and IPO proceeds utilization.
Injecto Polymers Other Announcement
Injecto Polymers Limited submitted its quarterly statement of investor grievances for the period ended 30th September 2026, reporting nil pending complaints.
Injecto Polymers Other Announcement
Injecto Polymers Ltd filed its quarterly shareholding pattern under Regulation 31. This is a routine compliance disclosure for shareholders.
Injecto Polymers Capital Structure Change
CapitalSquare Financial Services, a market maker, bought 958,800 Injecto Polymers shares (4.61%) on the open market, raising its stake to 5.97%. No transaction price was disclosed.